Citigroup’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-593
| Closed | -$1.31K | – | 4918 |
|
|
2024
Q4 | $1.31K | Buy |
+593
| New | +$1.31K | ﹤0.01% | 4707 |
|
|
2022
Q4 | – | Sell |
-876
| Closed | -$6K | – | 5011 |
|
|
2022
Q3 | $6K | Buy |
876
+778
| +794% | +$5.33K | ﹤0.01% | 4406 |
|
|
2022
Q2 | $1K | Sell |
98
-1,423
| -94% | -$14.5K | ﹤0.01% | 5253 |
|
|
2022
Q1 | $37K | Buy |
1,521
+1,187
| +355% | +$28.9K | ﹤0.01% | 4152 |
|
|
2021
Q4 | $16K | Buy |
334
+286
| +596% | +$13.7K | ﹤0.01% | 4682 |
|
|
2021
Q3 | $4K | Buy |
48
+39
| +433% | +$3.25K | ﹤0.01% | 4846 |
|
|
2021
Q2 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 5358 |
|